FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Regent Pacific Group Limited Stock AnalysisComprehensive stock analysis for Regent Pacific Group Limited (RPGLF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRPGLF
RPGLF
Regent Pacific Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RPGLF
Home🔹Stocks🔹Regent Pacific Group Limited

Regent Pacific Group Limited

RPGLF•OTC

Regent Pacific Group Limited

RPGLF•OTC
Market cap
$36.48M
Sentiment

Your view on RPGLF

Mkt Cap
$36.48M
Sentiment
Your view
RPGLF
Regent Pacific Group Limited
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RPGLF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Regent Pacific Group Limited

Industry
Asset Management
Sector
Financial Services
CEO
Jamie Alexander Gibson
Headquarters
Henley Building, Central, HK
Industry
Asset Management
Sector
Financial Services
CEO
Jamie Alexander Gibson
Headquarters
Henley Building, Central, HK
Description

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News